Effects of Transcatheter Aortic Valve Implantation on Left Ventricular Function And Coronary Hemodynamics

Effects of Transcatheter Aortic Valve Implantation on Left Ventricular Function And Coronary Hemodynamics - Effects of TAVI on LVF and coronary hemodynamics

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39853

Enrollment

Registered

2012-10-09

Start date

2012-10-15

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic valve narrowing aortic valve stenosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: transfemoral transcatheter aortic valve implantation

Exclusion criteria

Exclusion criteria: coronary arteries considered unsuitable by treating interventional cardiologist.

Design outcomes

Primary

Measure	Time frame
The short and long term change in left ventricular function after transcatheter aortic valve implantation, measured invasively by means of PV-loops and non-invasively with echocardiography and cardiac CT and MRI.	—

Secondary

Measure	Time frame
The secondary study parameters compared with baseline and, where possible, compared between the TAVI and SAVR are: invasively measured LV systolic and diastolic properties, coronary flow characteristics, LV ejection fraction, LV mass, LV myocardial perfusion, flow properties across the aortic valve, presence/amount of aortic and mitral regurgitation, right ventricular function, cardiac conduction, mortality and morbidity, NYHA functional class and quality of life.	—

Measure

Time frame

The secondary study parameters compared with baseline and, where possible, compared between the TAVI and SAVR are: invasively measured LV systolic and diastolic properties, coronary flow characteristics, LV ejection fraction, LV mass, LV myocardial perfusion, flow properties across the aortic valve, presence/amount of aortic and mitral regurgitation, right ventricular function, cardiac conduction, mortality and morbidity, NYHA functional class and quality of life.

—

Countries

Netherlands

Outcome results